D
Lantern Pharma Inc. LTRN
$4.44 -$0.13-2.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 6.18M 6.12M 6.09M 5.77M 5.62M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.50M 21.26M 22.22M 21.20M 19.54M
Operating Income -20.50M -21.26M -22.22M -21.20M -19.54M
Income Before Tax -19.25M -19.88M -20.78M -19.09M -17.75M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -19.25 -19.88 -20.78 -19.09 -17.75
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -19.25M -19.88M -20.78M -19.09M -17.75M
EBIT -20.50M -21.26M -22.22M -21.20M -19.54M
EBITDA -20.48M -21.24M -22.20M -21.18M -19.53M
EPS Basic -1.78 -1.84 -1.93 -1.78 -1.65
Normalized Basic EPS -1.11 -1.15 -1.19 -1.11 -1.03
EPS Diluted -1.78 -1.84 -1.93 -1.78 -1.65
Normalized Diluted EPS -1.11 -1.15 -1.19 -1.11 -1.03
Average Basic Shares Outstanding 43.21M 43.19M 43.15M 43.00M 43.09M
Average Diluted Shares Outstanding 43.21M 43.19M 43.15M 43.00M 43.09M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --